[Round table conference--present status and the future of treatment of leukemia].
D000208:Acute Disease; D001215:Asparaginase / Q000627:therapeutic use; D003561:Cytarabine / Q000494:pharmacology; D003630:Daunorubicin / Q000627:therapeutic use; D005972:Glutaminase / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D007951:Leukemia, Myeloid / Q000628:therapy; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D014750:Vincristine; D014747:Vinblastine; D001215:Asparaginase; D005972:Glutaminase; D003630:Daunorubicin